200 related articles for article (PubMed ID: 28295365)
1. Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascade.
LeBlanc VG; Firme M; Song J; Chan SY; Lee MH; Yip S; Chittaranjan S; Marra MA
J Pathol; 2017 Jun; 242(2):206-220. PubMed ID: 28295365
[TBL] [Abstract][Full Text] [Related]
2. Integrative multi-omic analysis reveals neurodevelopmental gene dysregulation in CIC-knockout and IDH1-mutant cells.
Lee SD; Song J; LeBlanc VG; Marra MA
J Pathol; 2022 Mar; 256(3):297-309. PubMed ID: 34767259
[TBL] [Abstract][Full Text] [Related]
3. Making heads or tails - the emergence of capicua (CIC) as an important multifunctional tumour suppressor.
Wong D; Yip S
J Pathol; 2020 Apr; 250(5):532-540. PubMed ID: 32073140
[TBL] [Abstract][Full Text] [Related]
4. Negative MAPK-ERK regulation sustains CIC-DUX4 oncoprotein expression in undifferentiated sarcoma.
Lin YK; Wu W; Ponce RK; Kim JW; Okimoto RA
Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20776-20784. PubMed ID: 32788348
[TBL] [Abstract][Full Text] [Related]
5. The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.
Weissmann S; Cloos PA; Sidoli S; Jensen ON; Pollard S; Helin K
Cancer Res; 2018 Aug; 78(15):4114-4125. PubMed ID: 29844126
[TBL] [Abstract][Full Text] [Related]
6. TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L.
Wong D; Sogerer L; Lee SS; Wong V; Lum A; Levine AB; Marra MA; Yip S
BMC Biol; 2020 Oct; 18(1):154. PubMed ID: 33115448
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic analysis of CIC and ATXN1L reveal a functional relationship exploited by cancer.
Wong D; Lounsbury K; Lum A; Song J; Chan S; LeBlanc V; Chittaranjan S; Marra M; Yip S
Oncogene; 2019 Jan; 38(2):273-290. PubMed ID: 30093628
[TBL] [Abstract][Full Text] [Related]
8. Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target.
Darabi S; Xiu J; Samec T; Kesari S; Carrillo J; Aulakh S; Walsh KM; Sengupta S; Sumrall A; Spetzler D; Glantz M; Demeure MJ
Med Oncol; 2023 Jun; 40(7):197. PubMed ID: 37291277
[TBL] [Abstract][Full Text] [Related]
9. Capicua in Human Cancer.
Kim JW; Ponce RK; Okimoto RA
Trends Cancer; 2021 Jan; 7(1):77-86. PubMed ID: 32978089
[TBL] [Abstract][Full Text] [Related]
10. RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma.
Eleveld TF; Schild L; Koster J; Zwijnenburg DA; Alles LK; Ebus ME; Volckmann R; Tijtgat GA; van Sluis P; Versteeg R; Molenaar JJ
Cancer Res; 2018 Nov; 78(21):6297-6307. PubMed ID: 30115695
[TBL] [Abstract][Full Text] [Related]
11. A double-edged sword: The world according to Capicua in cancer.
Tanaka M; Yoshimoto T; Nakamura T
Cancer Sci; 2017 Dec; 108(12):2319-2325. PubMed ID: 28985030
[TBL] [Abstract][Full Text] [Related]
12. CIC reduces xCT/SLC7A11 expression and glutamate release in glioma.
Park JW; Kilic O; Deo M; Jimenez-Cowell K; Demirdizen E; Kim H; Turcan Ş
Acta Neuropathol Commun; 2023 Jan; 11(1):13. PubMed ID: 36647117
[TBL] [Abstract][Full Text] [Related]
13. Multi-Omic Analysis of CIC's Functional Networks Reveals Novel Interaction Partners and a Potential Role in Mitotic Fidelity.
Takemon Y; LeBlanc VG; Song J; Chan SY; Lee SD; Trinh DL; Ahmad ST; Brothers WR; Corbett RD; Gagliardi A; Moradian A; Cairncross JG; Yip S; Aparicio SAJR; Chan JA; Hughes CS; Morin GB; Gorski SM; Chittaranjan S; Marra MA
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345142
[No Abstract] [Full Text] [Related]
14. The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer.
Simón-Carrasco L; Jiménez G; Barbacid M; Drosten M
Cell Cycle; 2018; 17(6):702-711. PubMed ID: 29578365
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of CIC does not associate with overexpression of ETV1 or MAP kinase pathway activation in gastrointestinal stromal tumors.
Schoppmann SF; Ricken G; Ilhan-Mutlu A; Nirtl N; Streubel B; Preusser M; Birner P
Cancer Invest; 2014 Aug; 32(7):363-7. PubMed ID: 24897389
[TBL] [Abstract][Full Text] [Related]
16. Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer.
Kim JW; Luck C; Wu W; Ponce RK; Lin YK; Gupta N; Okimoto RA
Cell Rep; 2022 Oct; 41(1):111443. PubMed ID: 36198276
[TBL] [Abstract][Full Text] [Related]
17.
Yang R; Chen LH; Hansen LJ; Carpenter AB; Moure CJ; Liu H; Pirozzi CJ; Diplas BH; Waitkus MS; Greer PK; Zhu H; McLendon RE; Bigner DD; He Y; Yan H
Cancer Res; 2017 Nov; 77(22):6097-6108. PubMed ID: 28939681
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma.
Simón-Carrasco L; Graña O; Salmón M; Jacob HKC; Gutierrez A; Jiménez G; Drosten M; Barbacid M
Genes Dev; 2017 Jul; 31(14):1456-1468. PubMed ID: 28827401
[TBL] [Abstract][Full Text] [Related]
19. Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors.
Ahmad ST; Rogers AD; Chen MJ; Dixit R; Adnani L; Frankiw LS; Lawn SO; Blough MD; Alshehri M; Wu W; Marra MA; Robbins SM; Cairncross JG; Schuurmans C; Chan JA
Nat Commun; 2019 May; 10(1):2000. PubMed ID: 31043608
[TBL] [Abstract][Full Text] [Related]
20. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
